Isomorphic Labs lands $2.1BN investment

Sir Demis Hassabis today hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google DeepMind and focuses on leveraging AI to help drug discovery as a “massive vote of confidence”. Isomorphic Labs today said it has raised $2.1bn in a Series B funding. The funding round was led by existing investor Thrive Capital, the US VC, with participation from existing backers Alphabet, Isomorphic's parent company, and its venture captial unit, GV.